The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

“This sets a baseline we can all believe in.” In its report, the CDC noted that about half of human antibiotic use is unnecessary, and such overuse could be leading to heightened resistance among ...

Payne confirmed that the CDC "does certainly intend to continue monitoring our RSV vaccine effectiveness in future seasons," garnering "hopefully more data to contribute to our understanding of ...

“The effectiveness depends on factors like age and health.” The 2024-25 influenza vaccine reduced the risk for influenza-associated outpatient visits and hospitalization, the CDC’s findings ...

The Centers for Disease Control and Prevention (CDC) published 2 sets of interim estimates: a 2024-2025 COVID-19 vaccine effectiveness (VE) analysis sourced from data from the Virtual SARS-CoV-2 ...